Insulin Does Not Hike Cancer Risk

ADA 2013 — CHICAGO — The use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes, according to a substudy of the prospective ORIGIN trial.


< Back to Listings